Skip to main content
. 2025 Apr 2;7(1):e001012. doi: 10.1136/bmjno-2024-001012

Table 1. Patient characteristics.

Variables Patients(n=41)
Age at onset, years, mean (SD) 66.9 (12.7)
Men, n (%) 20 (49)
Bulbar onset, n (%) 7 (17)
Age at diagnosis, years, mean (SD) 68.3 (12.5)
Duration from symptom onset to diagnosis, months, mean (SD) 16.6 (12.3)
Revised El Escorial criteria at diagnosis, definite or probable, n (%) 25 (61)
%FVC at diagnosis, %, mean (SD) 74.8 (29.2)
ALSFRS-R at diagnosis, mean (SD) 35.3 (8.2)
BMI, kg/m2, mean (SD) 20.6 (3.6)
sNfL, pg/mL, median (IQR) 113(72.9–155)*
cNfL, pg/mL, median (IQR) 7503(3981–10,949)†
*

Calculated for 42 samples. Calculated for .

†

Calculated for 36 samples.

ALSFRS-RAmyotrophic Lateral Sclerosis Functional Rating Scale RevisedBMIbody mass indexcNfLcerebrospinal fluid neurofilament light chain%FVCpercentage of predicted forced vital capacitysNfLserum neurofilament light chain